paclitaxel has been researched along with Dysesthesia in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (35.00) | 18.2507 |
2000's | 9 (45.00) | 29.6817 |
2010's | 4 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atherton, PJ; Lafky, J; Loprinzi, CL; Pachman, DR; Ruddy, KJ; Seisler, D; Shinde, SS; Soori, G | 1 |
Cheng, L; Guo, Y; Hu, L; Lv, QL; Qin, CZ; Wu, NY; Zhou, HH | 1 |
Cooley-Zgela, T; Gius, D; Morris, JC; Sharp, H; Singh, AK; Van Waes, C | 1 |
Jones, HR; Srinivasan, J | 1 |
Khasraw, M; Murphy, CG; Seidman, AD | 1 |
Aranishi, T; Hausheer, FH; Katsumata, N; Kuranami, M; Kuroi, K; Makino, H; Morita, S; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takeuchi, A; Watanabe, T | 1 |
Chiu, HC; Chu, CY; Yang, CH | 1 |
Durand, JP; Goldwasser, F | 1 |
Dellon, AL; Livengood, MS; Maloney, CT; Swier, P; Werter, S | 1 |
Chao, TY; Hong, RL; Hsieh, RK; Hwang, WS; Kao, WY; Lin, CH; Wang, CH | 1 |
Fujino, M; Maruhashi, K; Mitsudou, Y; Nakamura, T; Shimomatsuya, T; Shiraishi, S; Yonezawa, K | 1 |
Burris, HA; Keeling, JH; Lowry, M; Medina, J; Von Hoff, DD; Zimmerman, GC | 1 |
Baker, WJ; Burris, HA; Keeling, JH; Von Hoff, D; Vukelja, SJ | 1 |
Alvarez-Vicent, J; Brandariz, A; Colomer, R; Cortés-Funes, H; Hitt, R; Hornedo, J; Mendiola, C; Sevilla, E | 1 |
Boesgaard, M; Dombernowsky, P; Gehl, J; Jensen, BV; Paaske, T | 1 |
Eisenhauer, E; Latreille, J; Paul, K; Shepherd, FA | 1 |
Hilkens, PH; Pronk, LC; van den Bent, MJ; van Putten, WL; Vecht, CJ; Verweij, J | 1 |
Bauknecht, T; du Bois, A; Lück, HJ; Meerpohl, HG; Mollenkopf, A; Rauchholz, M; Schlaich, M; Wechsel, U | 1 |
Chiu, HC; Chu, CY; Hsiao, GH; Yang, CH; Yang, CY | 1 |
Bhupalam, L; Fleming, DR; Glisson, SD; Goldsmith, GH; LaRocca, RV; Michelson, GD | 1 |
8 trial(s) available for paclitaxel and Dysesthesia
Article | Year |
---|---|
Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.
Topics: Acute Pain; Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypesthesia; Male; Middle Aged; Neoplasms; Paclitaxel; Paresthesia; Peripheral Nervous System Diseases; Pilot Projects; Placebos; Pregabalin; Quality of Life; Surveys and Questionnaires | 2016 |
High incidence of oral dysesthesias on a trial of gefitinib, Paclitaxel, and concurrent external beam radiation for locally advanced head and neck cancers.
Topics: Adult; Aged; Amines; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Gefitinib; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Paresthesia; Prognosis; Quinazolines; Radiation Injuries; Radiotherapy; Stomatitis | 2008 |
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Female; Humans; Middle Aged; Neurotoxicity Syndromes; Paclitaxel; Paresthesia; Peripheral Nervous System Diseases; Quality of Life; Surveys and Questionnaires; Taxoids | 2012 |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Doxorubicin; Drug Administration Schedule; Female; Fever; Foot Dermatoses; Hand Dermatoses; Humans; Liposomes; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Paresthesia; Polyethylene Glycols; Salvage Therapy; Treatment Outcome | 2008 |
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carcinoma; Cisplatin; Combined Modality Therapy; Disease Progression; Dose-Response Relationship, Drug; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Paresthesia; Remission Induction; Treatment Outcome | 1995 |
Phase I dose-escalation trial of paclitaxel and ifosfamide in patients with advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carcinoma, Non-Small-Cell Lung; Confusion; Dexamethasone; Diphenhydramine; Drug Tolerance; Female; Hematuria; Humans; Ifosfamide; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Muscular Diseases; Neutropenia; Paclitaxel; Paresthesia; Survival Rate; Treatment Outcome | 1996 |
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Nervous System Diseases; Paclitaxel; Paresthesia; Taxoids | 1997 |
Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Deoxycytidine; Diarrhea; Esophageal Neoplasms; Exanthema; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Unknown Primary; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Paresthesia; Urinary Bladder Neoplasms; Vomiting | 2000 |
12 other study(ies) available for paclitaxel and Dysesthesia
Article | Year |
---|---|
Genetic variation of CYP3A5 influences paclitaxel/carboplatin-induced toxicity in Chinese epithelial ovarian cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Marrow; Carboplatin; Carcinoma, Ovarian Epithelial; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Leukocyte Count; Leukopenia; Middle Aged; Neoplasms, Glandular and Epithelial; Neutrophils; Ovarian Neoplasms; Paclitaxel; Paresthesia; Pharmacogenomic Variants; Prospective Studies | 2016 |
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Coronary Restenosis; Disease Susceptibility; Drug-Eluting Stents; Humans; Male; Neural Conduction; Paclitaxel; Paresthesia; Polyneuropathies; Recurrence; Sensation Disorders; Sjogren's Syndrome | 2009 |
Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Over Studies; Disease Progression; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Liposomes; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Paresthesia; Polyethylene Glycols; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2010 |
Fixed erythrodysaesthesia plaque due to gemcitabine and epirubicin treatment.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Eruptions; Epirubicin; Erythema; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Paresthesia; Skin; Taxoids | 2002 |
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
Topics: Adenocarcinoma; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Female; Humans; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Paresthesia; Sensation Disorders; Venlafaxine Hydrochloride | 2002 |
Chemotherapy-induced neuropathy: treatment by decompression of peripheral nerves.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carpal Tunnel Syndrome; Cisplatin; Decompression, Surgical; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hand; Humans; Leg; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Nerve Compression Syndromes; Neuralgia; Ovarian Neoplasms; Paclitaxel; Pain Measurement; Paresthesia; Peripheral Nervous System Diseases; Treatment Outcome; Vincristine; Wrist | 2004 |
[A case of severe hand-foot syndrome caused by capecitabine].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Paresthesia; Postoperative Period; Syndrome | 2007 |
Prevention of docetaxel-induced erythrodysesthesia with local hypothermia.
Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Humans; Hypothermia, Induced; Paclitaxel; Paresthesia; Taxoids | 1994 |
Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with taxotere.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Erythema; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Paclitaxel; Paresthesia; Pyridoxine; Taxoids | 1993 |
Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Alopecia; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Doxorubicin; Female; Heart; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Muscular Diseases; Nausea; Neoplasm Metastasis; Neutropenia; Paclitaxel; Pain; Paresthesia; Remission Induction; Stroke Volume; Ventricular Function, Left; Vomiting | 1996 |
Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Paresthesia; Psychomotor Performance; Reflex, Stretch; Surveys and Questionnaires | 1999 |
Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
Topics: Adult; Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Female; Humans; Injections, Intravenous; Male; Middle Aged; Paclitaxel; Paresthesia | 2000 |